These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36504336)

  • 41. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
    Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
    Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018.
    Kim SS; Flannery B; Foppa IM; Chung JR; Nowalk MP; Zimmerman RK; Gaglani M; Monto AS; Martin ET; Belongia EA; McLean HQ; Jackson ML; Jackson LA; Patel M
    Clin Infect Dis; 2021 Aug; 73(3):497-505. PubMed ID: 32505128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.
    Drori Y; Pando R; Sefty H; Rosenberg A; Mendelson E; Keinan-Boker L; Shohat T; Mandelboim M; Glatman-Freedman A;
    Vaccine; 2020 Dec; 38(52):8387-8395. PubMed ID: 33243633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. End-of-season influenza vaccine effectiveness during the Southern Hemisphere 2022 influenza season - Chile, Paraguay, and Uruguay.
    Chard AN; Nogareda F; Regan AK; Barraza MFO; Fasce RA; Vergara N; Avendaño M; Penayo E; Vázquez C; Von Horoch M; Michel F; Alfonso A; Mogdasy C; Chiparelli H; Goñi N; Alegretti M; Loayza S; Couto P; Rodriguez A; Salas D; Fowlkes AL; Azziz-Baumgartner E
    Int J Infect Dis; 2023 Sep; 134():39-44. PubMed ID: 37201863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
    Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
    J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Regan AK; Fielding JE; Chilver MB; Carville KS; Minney-Smith CA; Grant KA; Thomson C; Hahesy T; Deng YM; Stocks N; Sullivan SG
    Vaccine; 2019 May; 37(19):2634-2641. PubMed ID: 30952499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Ghamande S; Shaver C; Murthy K; Raiyani C; White HD; Lat T; Arroliga AC; Wyatt D; Talbot HK; Martin ET; Monto AS; Zimmerman RK; Middleton DB; Silveira FP; Ferdinands JM; Patel MM; Gaglani M
    Clin Infect Dis; 2022 Apr; 74(8):1329-1337. PubMed ID: 34320171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.
    Pebody R; Warburton F; Andrews N; Ellis J; von Wissmann B; Robertson C; Yonova I; Cottrell S; Gallagher N; Green H; Thompson C; Galiano M; Marques D; Gunson R; Reynolds A; Moore C; Mullett D; Pathirannehelage S; Donati M; Johnston J; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2015; 20(36):. PubMed ID: 26535911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Martin ET; Cheng C; Petrie JG; Alyanak E; Gaglani M; Middleton DB; Ghamande S; Silveira FP; Murthy K; Zimmerman RK; Monto AS; Trabue C; Talbot HK; Ferdinands JM;
    J Infect Dis; 2021 Jun; 223(12):2062-2071. PubMed ID: 33140094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22.
    Melidou A; Ködmön C; Nahapetyan K; Kraus A; Alm E; Adlhoch C; Mooks P; Dave N; Carvalho C; Meslé MM; Daniels R; Pebody R; ;
    Euro Surveill; 2022 Apr; 27(15):. PubMed ID: 35426364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
    Adams K; Weber ZA; Yang DH; Klein NP; DeSilva MB; Dascomb K; Irving SA; Naleway AL; Rao S; Gaglani M; Flannery B; Garg S; Kharbanda AB; Grannis SJ; Ong TC; Embi PJ; Natarajan K; Fireman B; Zerbo O; Goddard K; Timbol J; Hansen JR; Grisel N; Arndorfer J; Ball SW; Dunne MM; Kirshner L; Chung JR; Tenforde MW
    Clin Infect Dis; 2024 Mar; 78(3):746-755. PubMed ID: 37972288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City.
    Hernández-Hernández VA; Higuera-Iglesias AL; Palma-Cortes G; Tapia-Trejo D; Ávila-Ríos S; González-Fernández RR; Pérez-Moreno LÁ; Zuñiga-Ramos JA; Guadarrama-Pérez C; Sandoval-Gutiérrez JL; Cabello-Gutiérrez C
    Int J Infect Dis; 2022 Dec; 125():114-119. PubMed ID: 36283676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
    Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
    Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.